Pharmaceutical Executive Global Digest -
The pharmaceutical sector needs re-address its anti-bribery policies and ensure that adequate measures are in place. Toby Duthie and David Lawler at Forensic Risk Alliance ask some searching questions about corruption in the sector and offer critical advice as the number of US and international enforcement actions continue to rise.
No items found.
Related expertise
Share
